The primary objective of this study is to collect safety and performance data on the Indigo Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).
Study Type
OBSERVATIONAL
Enrollment
119
Indigo Aspiration System
Stanford University Medical Center
Stanford, California, United States
Danbury Hospital
Danbury, Connecticut, United States
Target Limb Salvage Rate
Proportion of participants who did not have a major amputation (above the level of the tarsometatarsal joint)
Time frame: 1-Month Post Procedure
Technical Success
Defined as TIMI 2/3 flow rate TIMI flow grade: Grade 0 No perfusion Grade 1 Perfusion past initial occlusion but no distal branch filling. Grade 2 Perfusion with incomplete or slow distal branch filling. Grade 3 Full perfusion with filling of all distal branches.
Time frame: Immediate Post Procedure
Modified Society for Vascular Surgery Runoff Score
Endpoint is change in modified SVS Runoff Score at post-procedure Modified SVS runoff score ranges from 1-19, with a higher score indicating more severe disease
Time frame: Pre Procedure and immediately Post Procedure
Improvement of Rutherford Classification
Improvement of one or more as compared to pre-procedure Rutherford classification: I.Viable Not immediately threatened IIa.Threatened Marginally Salvageable if promptly treated IIb. Threatened Immediately Salvageable with immediate revascularization III. Irreversible
Time frame: Up to discharge or 7 days, whichever occurred first
Vessel Patency
Patency is defined as a target lesion without a hemodynamically significant stenosis /reocclusion on duplex ultrasound (\>50 %, ) and without target lesion reintervention (TLR ).
Time frame: 1-Month Post-Procedure
Target Limb Salvage Rate
Proportion of participants who did not have a major amputation (above the level of the tarsometatarsal joint)
Time frame: 12-Months Post Procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Manatee Memorial Hospital
Bradenton, Florida, United States
Baptist Hospital of Miami
Miami, Florida, United States
University of Maryland
Baltimore, Maryland, United States
Albany Medical Center
Albany, New York, United States
Tisch Hospital NYU Langone Health
New York, New York, United States
NC Heart and Vascular Research
Cary, North Carolina, United States
Sanger Heart & Vascular Institute
Charlotte, North Carolina, United States
Trihealth Good Samaritan Hospital of Cincinnati
Cincinnati, Ohio, United States
...and 7 more locations
Rates of Device Related Serious Adverse Events (SAEs)
A SAE is an event that led to death, led to a serious deterioration in the health of the patient that resulted in life-threatening illness or injury, resulted in chronic disease, resulted in permanent impairment of a body structure or a body function, required in-patient hospitalization or prolongation of existing hospitalization, resulted in medical or surgical intervention to arrest permanent impairment to body structure or a body function, led to fetal distress, fetal death or a congenital abnormality or birth defect
Time frame: Up until study completion, at approximately 12-Months
Major Bleeding Peri-procedure
Fatal or leading to a drop in hemoglobin of ≥5 g /dl, or significant hypotension with the need for inotropes, or requiring surgery (other than vascular site repair ), or symptomatic intracranial hemorrhage (ICH ), or requiring transfusion of two or three units of red blood cells or equivalent whole blood
Time frame: within 2 days of procedure
Mortality
Death due to any cause
Time frame: 12-Months